◀ Back to MET

FGFR3 — MET

Text-mined interactions from Literome

Pal et al., Mol Cancer Ther 2012 (Carcinoma, Renal Cell...) : Pharmacologic strategies to block other potentially relevant signaling pathways, such as fibroblast growth factor receptor or MET inhibition , are also in various stages of development
Yau et al., Am J Physiol 1986 : Met-enkephalin ( 8.7 X 10 ( -8 ) M ) inhibited ACh release evoked by either substance P ( 3.7 X 10 ( -8 ) M ) or neurotensin ( 7.5 X 10 ( -11 ) M ), and this inhibition could be reversed by naloxone ( 5 X 10 ( -8 ) to 5 X 10 ( -5 ) M )
Kanyicska et al., Pol J Pharmacol Pharm 1985 (Catalepsy) : Inhibition of Na/K ATPase by ouabain led to an increase of striatal acetylcholine (Ach) release, which was enhanced by Met-enkephalin